111
views
0
recommends
+1 Recommend
0
shares
    • Review: found
    Is Open Access

    Review of 'Norovirus: Vaccine Challenges and Development'

    AUTHOR
    Bookmark
    5
    Norovirus: Vaccine Challenges and DevelopmentCrossref
    This article reviews the challenges of noroviruses and development of vaccines to combat them
    Average rating:
        Rated 5 of 5.
    Level of importance:
        Rated 5 of 5.
    Level of validity:
        Rated 4 of 5.
    Level of completeness:
        Rated 5 of 5.
    Level of comprehensibility:
        Rated 5 of 5.
    Competing interests:
    None

    Reviewed article

    • Record: found
    • Abstract: found
    • Article: found
    Is Open Access

    Norovirus: Vaccine Challenges and Development

    Noroviruses are a group of single-stranded RNA pathogens that cause acute gastroenteritis worldwide. Due to the high rates of mutation and evolution in the viruses, creating an effective vaccine to treat norovirus has been difficult. Factors such as the type of vaccine – live attenuated, subunit, or virus like particles – and target age group have limited progress in development. To better understand the best vaccine types and target groups for norovirus vaccine development, continuous research on the subjects will be encouraged. It will be shown that use of virus-like particles (VLPs) and a pediatric target group are the most effective options due to the versatility of VLPs and higher projected norovirus prevention rates for pediatric vaccination. The result of research will be useful to scientists creating norovirus vaccines and will help provide new perspectives for future research.
      Bookmark

      Review information

      10.14293/S2199-1006.1.SOR-LIFE.APYGOKU.v1.RCQJAG
      This work has been published open access under Creative Commons Attribution License CC BY 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com.

      Microbiology & Virology,Life sciences
      challenges,development,norovirus,vaccine
      ScienceOpen disciplines:
      Keywords:

      Review text

      The article should be published after this minor correction. When there are more than two authors, the first author should be mentioned followed by et. al.

      Comments

      Comment on this review

      Version and Review History